Pediatric Neurology
Volume 30, Issue 1 , Pages 57-60 , January 2004

Atypical childhood Wilson's disease

  • Martha D Carlson, MD, PhD

      Affiliations

    • Division of Pediatric Neurology, Departments of Pediatrics and Neurology, University of Michigan, Ann Arbor, Michigan, USA
    • Corresponding Author InformationCommunications should be addressed to:Dr. Carlson; Pediatric Neurology Metabolic Clinic; Box 0202/L3222; Women's Hospital; University of Michigan Health System; 1500 East Medical Center Drive; Ann Arbor, MI 48109-0202, USA.
    • ,
  • Majeed Al-Mateen, MD

      Affiliations

    • Mary Bridge Children's Hospital, Tacoma, Washington, USA
    • Department of Neurology, University of Washington, Seattle, Washington, USA
    • ,
  • George J Brewer, MD

      Affiliations

    • Departments of Human Genetics and Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA

Received 25 March 2003 ,Accepted 28 May 2003.

References 

  1. Brewer GJ. Wilson's disease (A clinician's guide to recognition, diagnosis, and management). Boston: Kluwer Academic Publishers; 2001; 1-27
  2. Sener RN. MR Imaging of Wilson's disease (Contrast enhancement of the cerebral cortex and corticomedullary junction). Comput Med Imaging Graphics. 1997;21:195–200
  3. Hedera P, Brewer GJ, Fink JK. White matter changes in Wilson's disease. Arch Neurol. 2002;59:866–867
  4. Brewer GJ, Hedera P, Kluin KJ, et al.  Treatment of Wilson disease with ammonium tetrathiomolybdate III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol. 2003;60:379–385
  5. Starosta-Rubinstein S, Young AB, Kluin K, et al.  Clinical assessment of 31 patients with Wilson's disease (Correlations with structural changes on magnetic resonance imaging). Arch Neurol. 1987;44:365–370
  6. Chu NS. Clinical, CT and evoked potential manifestations in Wilson's disease with cerebral white matter involvement. Clin Neurol Neurosurg. 1989;91:45–51
  7. Le Fort D, Deleplanque B, Louiset P, Pautrizel B, Loiseau P. Wilson's disease (Demonstration of lesions of the cortex and white matter by MRI). Rev Neurol (Paris). 1988;144:365–367
  8. Shimoji A, Miyakawa T, Watanabe K, Yamashita K, Katsuragi S, Kabashima K. Wilson's disease with extensive degeneration of cerebral white matter and cortex. Jpn J Psychiatry Neurol. 1987;41:709–717
  9. Finlayson MH, Superville B. Distribution of cerebral lesions in acquired hepatocerebral degeneration. Brain. 1981;104(Pt 1):79–95
  10. Miyakawa T, Murayama E. An autopsy case of the “demyelinating type” of Wilson's disease. Acta Neuropathol (Berl). 1976;35:235–241
  11. Saunders-Pullman R, Braun I, Bressman S. Pediatric movement disorders (review). Child Adolesc Psychiatr Clin N Am. 1999;8:747–765
  12. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000;343:1833–1838

PII: S0887-8994(03)00422-3

doi: 10.1016/S0887-8994(03)00422-3

Pediatric Neurology
Volume 30, Issue 1 , Pages 57-60 , January 2004

Article Tools

* Image Usage & Resolution